Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms
Lung cancer continues to be a leading cause of cancer-related mortality worldwide, with survival rates stubbornly low despite significant advancements in conventional therapies. The limited effectiveness of traditional immunotherapies, particularly in advanced stages of the disease, highlights an ur...
Saved in:
| Main Authors: | Alireza Pazoki, Sepehr Dadfar, Atefe Alirezaee, Valentyn Oksenych, Dariush Haghmorad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1617352/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
by: Dariush Haghmorad, et al.
Published: (2025-03-01) -
The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis
by: Sepehr Dadfar, et al.
Published: (2024-09-01) -
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy
by: Chinmay T. Jani, et al.
Published: (2025-12-01) -
Research progress of tumor vaccines in the treatment of prostate cancer
by: Chen Zheng, et al.
Published: (2024-02-01) -
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
by: Alireza Shariati, et al.
Published: (2024-12-01)